Ece Karabulut’s Post

"Behavioral “nudges,” such as text messaging women ahead of their appointment, can help increase adherence to regular mammography screening, according to new research published Monday in JAMA Internal Medicine." 📱MagView's Text Message Module can: *Send customized automated reminders to help patients stay on track for mammograms and follow-ups, *Reduce no-shows *Eliminate reminder letters https://lnkd.in/g2Bsauk3

Read how our Lightning Bolt® 12 and Lightning Bolt 6X with TraX™ are advancing arterial thrombectomy with this case study from Indiana University Health in Indianapolis: https://lnkd.in/gCBiMzuX

🫁Respiratory Muscle Training (#RMT) is proving to be a powerful tool in the #recovery of post-#COVID-19 patients. 📚 A systematic review of recent studies (Xavier et al., 2024) shows that RMT significantly improves respiratory #strength, reduces #dyspnea, and enhances overall #qualityoflife 💪As we continue to support those recovering from COVID-19, integrating RMT into rehabilitation protocols could make a substantial difference in patient outcomes. For those in healthcare and rehabilitation, this is a promising area worth exploring further. Find more information on our website: www.emst150.com #Healthcare #Rehabilitation #COVID19Recovery #longCOVID #covid #rmst #postcovid Xavier, D. M., Abreu, R. A. L., Corrêa, F. G., Silva, W. T., Silva, S. N., Galvão, E. L., & do Nascimento Junior, M. G. (2024). Effects of respiratory muscular training in post-COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials. *BMC Sports Science, Medicine and Rehabilitation, 16*(1), 181. https://lnkd.in/dnQFAybP

Action Duchenne is excited to share the news that the National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Vamorolone for the treatment of Duchenne muscular dystrophy (DMD). This positive decision offers a step forward in the management of DMD, expanding the range of treatment options available to patients and their families, a currently urgent unmet need. With the NICE’s approval, the NHS will now consider the recommendation and determine their next steps in this regulatory process to make Vamorolone accessible to eligible patients under the NHS in England. Find out more on our website: https://lnkd.in/edDfnWFN

Cheers to PI Dr. Dany Jacob, Dana King, Eric Burgett, Hall Jamie, and the rest of the MICRO2 study team at Saint Luke's Health System on enrolling their first MICRO2 patient! Prior to the initiation of the MICRO2 trial, the recently published MICRO trial demonstrated CardioFlux MCG's ability to diagnose coronary microvascular dysfunction (CMD) in the space of a 90-second, no-contact scan - a first-of-its-kind exploration in what is now six decades of research into MCG. In contrast, the current gold standard for diagnosis is invasive coronary functional angiography, an option which remains practically out-of-reach for a majority of patients who likely suffer from CMD today. Worse still, clinician recognition of CMD and its impact on long-term outcomes remains low, perhaps due in part to the lack of simple, highly accessible options for diagnosis today. We’re excited to partner with clinicians, like Dr. Jacob and the rest of his team, who are actively working to address this unmet need! #MICRO2 #CardioFluxMCG #microvascular #CMD #myocardialischemia #INOCA

Women have long been underrepresented in clinical heart research — leading to gaps in detecting, treating, and setting standards of care for heart disease. Further, published data shows that women are up to 35% less likely than men to receive either of the available treatment options (TAVR and SAVR) to treat aortic stenosis.¹﹐² Earlier this month, we hosted a powerful roundtable discussion focused on reshaping the future of women’s heart health. We saw clinicians, patient advocates, and policy leaders all come together in one space to work towards the same goal - elevating the future of women’s health. This comes on the heels of #SMARTtrial data showing that Evolut™️ #TAVR delivers superior valve performance in women with a small annulus at 1 year versus SAPIEN™* platform.³ At Medtronic, we will continue helping empower and amplify the voices of women while driving awareness on women’s heart valve disease and #AorticStenosis. Huge thanks to WomenHeart: The National Coalition for Women with Heart Disease, Women As One, https://bit.ly/4cmUTCG and The Atlantic for your commitment to women’s heart health and partnership for this event! Watch the event replay here: https://bit.ly/4es6lih #WomensHealth #HeartHealth 1. Paquin A, et al. Can J Cardiol. 2021;37:E2. 2. Rice CT, et al. Open Heart. 2023;10:e002371. 3. Herrmann HC, et al. N Engl J Med. Published online April 7, 2024. Valve performance defined as freedom from bioprosthetic valve dysfunction. Risk info: https://bit.ly/4eC7cNt TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and the need for a permanent pacemaker.

Reflecting on 2024 and Looking Ahead! As 2024 comes to a close, we’re proud of the lives we’ve touched and the progress we’ve made at Top One Research Group. From our work in cardiology, and obesity to advancing innovative treatments for diabetes and pulmonary diseases, we’ve had the privilege of being part of transformative projects that are truly changing lives. This year, we’ve seen firsthand how research can bring hope, healing, and new possibilities to patients. Whether it was through improving treatment options, accelerating timelines, or enhancing patient care, we’ve made a tangible impact. Each study has been a step forward, and each breakthrough has brought us closer to our ultimate goal: Shaping a healthier future. But the journey doesn’t stop here. As we step into 2025, we’re more motivated than ever to continue pushing boundaries, expanding our reach, and making an even greater impact on healthcare. Together, we will keep driving change, forging stronger partnerships, and empowering patients with the best possible care. Here’s to a year of continued success, new opportunities, and even greater achievements ahead. Let’s make 2025 a year to remember! 💪🚀 #Flashback2024 #MakingADifference #HealthcareInnovation #ClinicalResearch #LifeChangingWork #StrongerTogether #2025Goals #ImpactfulProgress #TORG #TopOneResearchGroup

Stroke is a race against time! Unfortunately, some patients end up in a hospital without acute stroke intervention services, leading to delayed therapy. 🚫 The Problem *Ambulances traditionally lack tools to diagnose and triage stroke patients to the appropriate hospital. ✅ The Innovative Solution: *The Smart Brain-Wave Cap by Amsterdam UMC ➡️ Prehospital EEG analysis detects ischemic strokes in real-time. ➡️ Determines the size of blockages to guide treatment decisions. ➡️ Directs patients to the correct hospital for specialized care. ✅Why It Matters 🔹 Faster pre-hospital diagnosis. 🔹 Reduces delays to the right facility immediately. 🔹 Proven Impact on >400 patients. For more on healthcare breakthroughs, subscribe to my VIP Newsletter: 👉 https://lnkd.in/dqFuMAJ3 #AIHealthcare #StrokeCare #PrehospitalDiagnosis #DigitalHealth #TheHotBleep #DrNik VC; Amsterdam UMC